HPV vaccine: Cervarix

Expert Opinion on Biological Therapy
Anne Szarewski

Abstract

Cervical cancer is a major cause of morbidity and mortality worldwide and is common in relatively young women. Cervical screening programs, while successful if properly carried out, are difficult and expensive to implement, and offer secondary, not primary prevention. Vaccination against the human papillomavirus (HPV), which is the major cause of cervical cancer, is a significant step forward. The data on Cervarix, the GSK HPV vaccine, are reviewed and placed in the context of HPV vaccination as a whole. A literature review using PubMed listed publications and official product websites has been carried out. The reader will gain an understanding of the issues involved in HPV vaccination and of the data to date. Cervarix has been shown to have high efficacy against disease associated with both HPV-16 and HPV-18. Its antibody response profile allows for optimism regarding the duration of immunity. The fact that it is a virus-like particle, rather than a live-virus vaccine, is reassuring regarding safety, as are the reasonably extensive safety data for the vaccine preparation so far accrued. Cross protection against oncogenic non-vaccine HPV types, in particular HPV-45, may be important in the prevention of cervical adenocarcinoma,...Continue Reading

References

Sep 1, 1991·American Journal of Obstetrics and Gynecology·C LermanD Smith
May 5, 1997·The American Journal of Medicine·L Koutsky
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J L Wolstenholme, D K Whynes
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Oct 6, 2001·Sexually Transmitted Infections·F Martin, M Bower
Feb 20, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Raphael P ViscidiRobert D Burk
Jul 21, 2004·Lancet·Julian PetoFiona E Matthews
Nov 10, 2004·British Journal of Cancer·D P FrenchT M Marteau
Nov 20, 2004·The Journal of Infectious Diseases·Nubia MuñozUNKNOWN Instituto Nacional de Cancerologia HPV Study Group
Jan 1, 2005·The Journal of Infectious Diseases·Geoffrey P Garnett
Apr 13, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M JacobJ Sellors
Oct 13, 2005·Vaccine·Margaret Stanley
Dec 2, 2005·Emerging Infectious Diseases·Matthew J GraingeDavid Jenkins
May 11, 2006·Current Medical Research and Opinion·R E BrownS Bénard
Aug 25, 2006·International Journal of Cancer. Journal International Du Cancer·Shiho MiuraHiroyuki Yoshikawa
Sep 5, 2006·Vaccine·D Maxwell Parkin, Freddie Bray
Sep 5, 2006·Vaccine·John T Schiller, Denise Nardelli-Haefliger
Sep 19, 2006·Gynecologic Oncology·UNKNOWN Society of Gynecologic Oncologists Education Resource Panel Writing groupJason Wright
Jan 16, 2007·Journal of Medical Screening·K S CuschieriH A Cubie
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
May 29, 2007·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Court PedersenUNKNOWN HPV Vaccine Adolescent Study Investigators Network
Aug 29, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Laura Eggertson
Jan 10, 2008·British Journal of Cancer·F X BoschS de Sanjosé
Jan 19, 2008·The Journal of Family Planning and Reproductive Health Care·Mark A Kane
May 17, 2008·American Journal of Epidemiology·Jill KoshiolJennifer S Smith
Sep 26, 2008·Diabetologia·B CarstensenUNKNOWN Steering Group of the National Diabetes Register

❮ Previous
Next ❯

Citations

Nov 27, 2010·International Journal of Public Health·Nadia DemarteauBaudouin Standaert
Jun 29, 2011·International Journal of Public Health·Abdelkader El HasnaouiBruno Detournay
Mar 23, 2013·Vaccine·J HornR T Mikolajczyk
Sep 20, 2011·Translational Research : the Journal of Laboratory and Clinical Medicine·Soumyabrata RoyRathindranath Baral
Aug 10, 2010·Protein Expression and Purification·John J KerriganQuinn Lu
May 1, 2010·Journal of Cellular Physiology·Giuseppina D'AndrilliAntonio Giordano
Aug 11, 2012·Journal of Medical Microbiology·George Creatsas, Efthimios Deligeoroglou
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Ala-Eddin Al MoustafaGhazi Alsbeih
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nadia DemarteauGeorges Van Kriekinge
Aug 7, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Poljak
Sep 8, 2017·Cost Effectiveness and Resource Allocation : C/E·Oliver DammWolfgang Greiner
Aug 19, 2016·Clinical and Vaccine Immunology : CVI·Katharina B LauerThomas J Blanchard
May 8, 2019·Epidemiology and Infection·Herney Andrés García-PerdomoAndrés Castillo
Jul 6, 2019·Frontiers in Plant Science·Ahmad IbrahimRichard Kormelink
May 10, 2018·The Cochrane Database of Systematic Reviews·Marc ArbynPierre Pl Martin-Hirsch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.